Cellectis SA (CLLS)
3.90
-0.09
(-2.26%)
USD |
NASDAQ |
Feb 20, 16:00
3.97
+0.07
(+1.79%)
After-Hours: 20:00
Cellectis SG&A Expense (Quarterly) : 5.184M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| EDAP TMS SA | 10.30M |
| DBV Technologies SA | 8.399M |
| Ascendis Pharma A/S | 158.13M |
| Akari Therapeutics Plc | 1.963M |
| Biodexa Pharmaceuticals Plc | -- |